COVID-19: Rapid test sensitivity with Omicron and where to swab
A couple of studies on the sensitivity of rapid tests with Omicron have recently been released. The first is a pre-print that evaluated 7 rapid tests ( medrxiv.org/content/10.110… ). 🧵1/ FYI @SabiVM,@imgrund,@DFisman
They found that detection of Omicron is the first variant of concern (VOC) that showed a tendency towards lower analytical sensitivity across tests. They found a considerable difference in sensitivity patterns between tests across variants including Omicron. 2/
The differences in analytical sensitivity between rapid tests might be explained by the different epitopes each test is looking for in the virus and potentially impacted differently from mutations in the nucleocapsid protein that most tests use (not the spike). 3/
If lower sensitivity is confirmed in clinical validations, that means rapid tests in the early stages of an Omicron infection when viral load is lower could be less reliable. 4/
You can see from the first graph that the Flowflex (ACON Biotech) rapid test listed as VII in the table was able to detect Omicron with a lower viral load than all the others. 5/
The rapid tests were:
I = Panbio COVID-19 Ag Rapid test device (Abbott)
II = Standard Q COVID-19 Ag (SD Biosensor/Roche)
III = Sure Status (Premier Medical Corporation)
IV = 2019-nCoV Antigen test (Wondfo)
6/
V = Beijng Tigsun Diagnostics Co. Ltd (Tigsun)
VI = Onsite COVID-19 Ag Rapid Test (CTK Biotech)
VII = Flowflex (ACON Biotech)
7/
A couple of the tests (III and VI) require a much higher viral load to detect Omicron than some of the others. One box height in the graph means double the amount of virus is required for detection which equals around one additional PCR cycle count (
Viral load doubling times with previous variants (D614G) was about 2.4 hours while Delta is much faster at 1.2-1.6 hours. 9/
If Omicron is similar that means in practical terms some of the rapid tests may need someone to be infected 2-4 hours longer for the viral load to be high enough to be detected compared with Delta. 10/
Dr. Mina believes these results may show that all tests will have slightly lower sensitivity, PCR included (
). A more aggressive, more efficient ability to infect a cell and take hold would appear in a study like this as lower sensitivity. 11/
That means someone could potentially get a negative test result when they are slightly contagious. This is another reason why rapid tests the night or day before are not a good indicator for your status now. 12/
Another study looked at the analytical sensitivity of 10 rapid tests with the Omicron variant ( journals.asm.org/doi/10.1128/jc… ). 13/
They found less of a difference between test results for Delta and Omicron than the study above. All 10 kits were able to detect Delta at 6.5 log10 copies/mL (PCR Ct 25.4) and Omicron at 6.39 log10 copies/mL (PCR Ct 25.8). 12/
None of the test kits detected Omicron at the lowest dilution 5.33 log10 copies/mL (PCR Ct 28.8). 13/
The tests with best sensitivity to Omicron are:
- Panbio (Abbott)
- Surescreen (BTNX)
- VivaDiag (VivaCheck Biotech)
Abbott and BTNX rapid tests are available in Canada but stock is limited. 16/
Where is the best place to swab for Omicron? A pre-print study looked at shallow nose (mid-turbinate) and throat (saliva) swabs for both Delta and Omicron to see which ones tested positive the most ( medrxiv.org/content/10.110… ). 17/
For Delta they found that shallow nose swabs tested positive 100% of the time in their tests while throat/saliva swabs only tested positive 71% of the time when compared with PCR tests. 18/
This completely flips with Omicron and 86% of shallow nose swabs tested positive while 100% of throat/saliva swabs tested positive. 19/
It is actually possible to get the best of both worlds by swabbing the throat first and then the nose. Here is a video showing the process ( ). 20/
Another example where a combine swab provides much better results (
COVID-19: Ontario and UK early estimates of Omicron severity
Both Ontario and the UK recently released reports on early estimates of Omicron severity with the UK also looking at data including children. H/T: @Billius27 & @ASPphysician 🧵1/
First, Ontario used a matched cohort study with 6,314 Omicron cases matched with at least 1 Delta case based on age, gender, and onset date ( publichealthontario.ca/-/media/docume… ). 2/
A big caveat to their study is the median age of cases was 30 for Delta and 28 for Omicron so a study population that was on the lower end of hospitalization risk in the first place. 3/
They both claim the the change in guidelines is based on science but I have yet to see anything released that actually shows the science they used for their decision making. 2/
For background, you may want to read this thread about when it is appropriate to use PCR, rapid tests, and antibody tests with their strengths and weaknesses (
COVID-19: When to use PCR, Rapid Tests, and Antibody Tests
A study looks at diagnostics for COVID-19 and their role to move from pandemic response to pandemic control ( thelancet.com/journals/lance… ). H/T: @EricTopol 🧵1/
There are 3 major methods for the detection of COVID-19 virus infection. Molecular tests (PCR) are highly sensitive and specific at detecting viral RNA and can detect it at very low levels. 2/
The PCR method of test is recommended by the WHO for confirming diagnosis of individuals who are symptomatic for activating public health measures. 3/
The posted PPE/N95 checklist (see image) is dated more than a year ago and still calls for N95 protection only when certain aerosol generating procedures (AGPs) are present. I fixed it for them... 2/
Ironically breathing, talking, exercising, shouting, and coughing generates more aerosols than the last two AGPs on their list (NIPPV and HHFNO) which were measured in this research study ( …-publications.onlinelibrary.wiley.com/doi/10.1111/an… ). 3/
[Part 2 of 2] COVID-19: Why respiratory viruses surge in winter
In part 1 we looked at the seasonality of respiratory viruses in the human population and the effect of environmental factors on stability and transmission of respiratory viruses (
We continue with part 2 focusing on the effect of environmental factors on the host airway antiviral defense ( annualreviews.org/doi/10.1146/an… ). 2/
The mucosal surface of the respiratory tract is continuously exposed to inhaled environmental air that contains pollutants and pathogens but there are multiple defense systems that prevent infection. 3/
In temperate regions, annual epidemics of the common cold and influenza hit the human population like clockwork in the winter season (barring pandemics) so why is that? 2/
There are multiple factors that affect respiratory virus transmission including seasonal environmental factors which modulate host airway immune response and affect viability and transmission of viruses. Human behaviours also affect rates. 3/